Display options
Cite
Janssen NAF, Nyga R, Vanderbeke L, et al. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis. Emerg Infect Dis. 2021;27(11):2892-2898doi: 10.3201/eid2711.211174.
Janssen, N. A. F., Nyga, R., Vanderbeke, L., Jacobs, C., Ergün, M., Buil, J. B., van Dijk, K., Altenburg, J., Bouman, C. S. C., van der Spoel, H. I., Rijnders, B. J. A., Dunbar, A., Schouten, J. A., Lagrou, K., Bourgeois, M., Reynders, M., van Regenmortel, N., Rutsaert, L., Lormans, P., Feys, S., Debavaye, Y., Tamion, F., Costa, D., Maizel, J., Dupont, H., Chouaki, T., Nseir, S., Sendid, B., Brüggemann, R. J. M., van de Veerdonk, F. L., Wauters, J., & Verweij, P. E. (2021). Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis. Emerging infectious diseases, 27(11), 2892-2898. https://doi.org/10.3201/eid2711.211174
Janssen, Nico A F, et al. "Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis." Emerging infectious diseases vol. 27,11 (2021): 2892-2898. doi: https://doi.org/10.3201/eid2711.211174
Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CSC, van der Spoel HI, Rijnders BJA, Dunbar A, Schouten JA, Lagrou K, Bourgeois M, Reynders M, van Regenmortel N, Rutsaert L, Lormans P, Feys S, Debavaye Y, Tamion F, Costa D, Maizel J, Dupont H, Chouaki T, Nseir S, Sendid B, Brüggemann RJM, van de Veerdonk FL, Wauters J, Verweij PE. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis. Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14. PMID: 34519638; PMCID: PMC8544971.
Copy Download .nbib Format: NLM
Share it on

Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14.

Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis.

Emerging infectious diseases

Nico A F Janssen, Rémy Nyga, Lore Vanderbeke, Cato Jacobs, Mehmet Ergün, Jochem B Buil, Karin van Dijk, Josje Altenburg, Catherine S C Bouman, Hans I van der Spoel, Bart J A Rijnders, Albert Dunbar, Jeroen A Schouten, Katrien Lagrou, Marc Bourgeois, Marijke Reynders, Niels van Regenmortel, Lynn Rutsaert, Piet Lormans, Simon Feys, Yves Debavaye, Fabienne Tamion, Damien Costa, Julien Maizel, Hervé Dupont, Taieb Chouaki, Saad Nseir, Boualem Sendid, Roger J M Brüggemann, Frank L van de Veerdonk, Joost Wauters, Paul E Verweij

PMID: 34519638 PMCID: PMC8544971 DOI: 10.3201/eid2711.211174

Abstract

We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in 2 cohorts. Several factors were independently associated with CAPA in 1 cohort and mortality rates were 43%-52%.

Keywords: Aspergillus; COVID-19; SARS; SARS-CoV-2; coronavirus; coronavirus disease; epidemiology; fungi; invasive pulmonary aspergillosis; mortality rates; mycology; respiratory infections; risk factors; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

References

  1. Lancet Respir Med. 2020 Jun;8(6):e48-e49 - PubMed
  2. Ann Intensive Care. 2020 Jun 1;10(1):71 - PubMed
  3. Lancet Infect Dis. 2021 Jun;21(6):e149-e162 - PubMed
  4. Lancet Microbe. 2020 Jun;1(2):e53-e55 - PubMed
  5. Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135 - PubMed
  6. Intensive Care Med. 2012 Nov;38(11):1761-8 - PubMed
  7. Mycoses. 2020 Jun;63(6):528-534 - PubMed
  8. Clin Infect Dis. 2021 Oct 5;73(7):e1634-e1644 - PubMed
  9. Am J Respir Crit Care Med. 2017 Apr 7;196(4):524-527 - PubMed
  10. Clin Microbiol Infect. 2020 Dec 13;: - PubMed
  11. Lancet Respir Med. 2018 Oct;6(10):782-792 - PubMed
  12. Clin Infect Dis. 2020 Jul 28;: - PubMed
  13. Clin Infect Dis. 2020 Sep 12;71(6):1367-1376 - PubMed
  14. Crit Care. 2020 Jun 5;24(1):299 - PubMed
  15. Clin Microbiol Infect. 2020 Dec;26(12):1706-1708 - PubMed

MeSH terms

Publication Types